| 摘要 |
FIELD: medicine, pharmaceutics.SUBSTANCE: invention refers to pharmaceutical industry, namely to RGD-bacteriochlorophyll conjugates which are targeted into domains of tumour necrosis and collected therein much longer than in non-necrotic domains to be used in the minimally invasive tumour-targeted imaging, tumour-targeted photodynamic therapy and/or interactive prediction of necrotic tumours.EFFECT: improving tumour imaging.16 cl, 38 ex, 34 dwg, 2 tbl |
